Edgewell Personal Care (EGZ) AI Stock Analysis

0 Followers

Edgewell Personal Care

(Frankfurt:EGZ)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Branded portfolio momentumSustained growth in Cremo, Hawaiian Tropic, Billie and branded Wet Shave indicates improving brand relevance and distribution. These assets can support repeat purchases, retailer shelf space and mix improvement beyond a single quarter.

Negative Factors

Material profitability deteriorationThe shift to a net loss and sharply lower operating margins weakens internal capital generation and reduces the cushion available for brand investment. Recovery depends on sustainable cost control, better mix and reduced promotional pressure.

Edgewell Personal Care (EGZ) vs. iShares MSCI Germany ETF (EWG)

Market Cap: EUR 1.34B
Dividend Yield: 1.90%
Average Volume (3M): 95
Price to Earnings (P/E): -14.6
Beta (1Y): 0.51
Revenue Growth: -13.21%
EPS Growth: -237.65%
Country: Germany
Employees: 6,700
Sector: Consumer Defensive
Sector Strength: 62
Industry: Household & Personal Products

Edgewell Personal Care Business Overview & Revenue Model

Company Description

Edgewell Personal Care Company, along with its associated businesses, is a global producer and distributor of a diverse range of personal care items. The company organizes its operations into three main divisions: Wet Shave, Sun and Skin Care, and Fe...

Edgewell Personal Care Earnings Call Summary

Earnings Call Date:Aug 05, 2026(Q3-2026)|% Change Since:14.18%|Next Earnings Date:Feb 09, 2027

Earnings Call SentimentNeutral

The call presented a mixed but constructive picture: management highlighted a return to organic sales growth, clear North American improvements, strong brand momentum across marquee brands (Cremo, Hawaiian Tropic, Billie), realized productivity savings, healthy Q3 operating cash flow, and an unchanged mid-point full-year outlook. Offsetting these positives were international weakness driven largely by transitory private-label supply disruptions, margin pressure from mix/inflation/promotions, lower GAAP EPS and reduced operating income versus prior year, and near-term elevated leverage associated with divestiture timing. Management emphasized that many headwinds are transitory, progress on the manufacturing consolidation is underway, and Q4 gross margin expansion is expected, but growth guidance for the year remains modest.

Positive Updates

Return to Organic Net Sales Growth

Organic net sales increased 1.1% in Q3, marking a return to growth after prior periods of pressure and providing momentum into the back half of fiscal '26.

Negative Updates

International Organic Sales Decline

International organic net sales declined 1.4% in Q3, negatively impacted by the Middle East conflict, private label supply disruptions, and a weaker-than-anticipated start to the sun season in Europe and Latin America.

Company Guidance

Edgewell reiterated and narrowed its fiscal 2026 guidance: organic net sales flat to +50 bps; adjusted EPS $1.80–$2.00; adjusted EBITDA $250–$260M; adjusted free cash flow (ex‑Feminine Care timing) ~$80–$110M; and adjusted net debt leverage to finish the year at ~3.3–3.4x (including an estimated 0.3–0.4x temporary negative turn from the Fem Care divestiture). Management also expects stronger Q4 (with mid‑single‑digit international growth and continued North America strength), material gross‑margin expansion in Q4 driven by productivity, cycling of one‑time items and favorable FX (though the full‑year gross‑margin rate was modestly reduced), and reiterated planned A&P investment levels; for context Q3 results included organic +1.1%, North America +3%, adjusted EBITDA $78.9M, adjusted EPS $0.72 (GAAP EPS $0.26), ~200 bps of productivity savings, A&P at 14.6% of sales, and operating cash flow of about $119M in Q3.

Edgewell Personal Care Risk Analysis

Edgewell Personal Care disclosed 28 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the "Production" category.

Production - Risks related to the company’s ability to manufacture goods and services

Latest Risks Added

0 New Risks

Edgewell Personal Care Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

DE:EGZ against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
CHD	78Outperform	$26.38B	34.36	18.21%	1.09%	1.70%	2.07%
PG	72Outperform	$390.92B	24.84	29.55%	2.58%	3.52%	-3.74%
UL	64Neutral	$141.29B	13.84	58.26%	3.38%	-17.45%	8.84%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
HELE	55Neutral	$893.52M	-8.73	-11.86%	―	0.52%	84.94%

* Consumer Defensive Sector Average

Performance Comparison

DE:EGZ and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
DE:EGZ	Edgewell Personal Care Co	26.80	10.87	68.28%
CHD	Church & Dwight Company	112.02	28.16	33.59%
HELE	Helen Of Troy	37.98	18.91	99.19%
PG	Procter & Gamble Company	167.67	23.88	16.61%
UL	Unilever plc	65.78	2.77	4.39%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Edgewell Personal Care AI Stock Analysis